PRISM Cannabis
New York, April 23, 2024 - PRISM MarketView - The Canadian cannabis company Village Farms International, Inc. (VFF) has returned 71% YTD, is up 26% in the past month and has returned 78% over the past year. Village Farms continues to report its successes and make recent ...

23 April 2024

PRISM View
New York, April 22, 2024 - PRISM MarketView - Today the technology company specializing in creating immersive 3D experiences of physical spaces Matterport, Inc. (MTTR) announced today that it has entered into a definitive agreement with CoStar Group, Inc. (CSGP) who will...

22 April 2024

PRISM Biotech
New York, April 22, 2024 - PRISM MarketView - Global biopharmaceutical company, YS Biopharma (Nasdaq: YS) has been granted clinical trial approval in the Philippines for its YS-HBV-002 immunotherapeutic vaccine for chronic hepatitis B virus (HBV) infection. YS expects to...

22 April 2024

PRISM Biotech
New York, April 19, 2024 - PRISM MarketView - Texas-based diagnostic tools company, Aspira Women’s Health (Nasdaq: AWH), has entered into a new agreement with Anthem Blue Cross in California for reimbursement coverage of the Company’s OvaSuiteSM portfolio of risk assessm...

19 April 2024

PRISM Biotech
New York, April 19, 2024 - PRISM MarketView - Biopharmaceutical company, Lipocine Inc. (Nasdaq: LPCN) has announced positive results from a Phase 2 clinical trial evaluating LPCN 2401 for improving body composition by gaining lean mass and reducing fat mass. Lipocine bel...

19 April 2024

PRISM Biotech
New York, April 18, 2024 - PRISM MarketView - In a crushing disappointment for Sage Therapeutics (Nasdaq: SAGE) and the Parkinson’s disease community, the company reported on Wednesday that its double-blind, placebo-controlled Phase 2 study of dalzanemdor (SAGE-718) in P...

18 April 2024

PRISM Biotech
New York, April 18, 2024 - PRISM MarketView - CorMedix Inc. (Nasdaq: CRMD) has announced that its DefenCath® (taurolidine and heparin) catheter lock solution (CLS) is now commercially available for inpatient use in the US. DefenCath® has received FDA approval for use in ...

18 April 2024

PRISM Biotech
New York, April 18, 2024 - PRISM MarketView - Shares in Femasys Inc. (Nasdaq: FEMY) rose 2.31% in morning trading on Thursday after the company announced that its CEO and Founder, Kathy Lee-Sepsick, has met with several members of Congress to discuss the current women’s ...

18 April 2024

PRISM Biotech
New York, April 18, 2024 - PRISM MarketView - atai Life Sciences’ (Nasdaq: ATAI) share price reached $2.20 in intraday trading on Wednesday, and rose a further 0.75% in morning trading on Thursday after the company announced the publication of the results of Beckley Psyt...

18 April 2024

PRISM Biotech
New York, April 18, 2024 - PRISM MarketView - PRISM Emerging Psychedelics Index company, Cybin, Inc (NYSE American: CYBN) has been granted an important patent in support of the company’s proprietary deuterated psilocybin analog program in Major Depressive Disorder (MDD)....

18 April 2024

33
34
35
36
37
38
39
We use cookies to run our website, analyze your use of our services, manage your online preference & personalize ad content. By accepting our cookies, you’ll get relevant content and social media features, personalized ads, and an enhanced browsing experience. To manage your choices, click „Cookie Settings”. Necessary cookies are required for the core website functionality and cannot be rejected. For more information, see our Cookie Policy.
Cookie settings
Cookies used on the site are categorized and below you can read about each category and allow or deny some or all of them, except for Necessary Cookies which are required to provide core website functionality. When categories that have been previously allowed are disabled, all cookies assigned to that category will be removed from your browser. You can see a list of cookies assigned to each category and detailed information on those cookies in the “Cookie Policy” tab.
Necessary cookies
Some cookies are required to provide core functionality. The website won't function properly without these cookies and they are enabled by default and cannot be disabled.
Preferences
Preference cookies enables the website to remember information to customize how the website looks or behaves for each user. This may include storing selected currency region, language or color theme.
Analytical cookies
Analytical cookies help us improve our website by collecting and reporting information on its usage.
Marketing cookies
Marketing cookies are used to track visitors across websites to allow publishers to display relevant and engaging advertisements. By enabling marketing cookies, you grant permission for personalized advertising across various platforms.